Key Takeaways IDEXX Laboratories exceeded earnings and revenue estimates on sales of its animal testing products and price ...

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

A substantial insider sell was reported on February 10, by M. Anne Szostak, Director at IDEXX Laboratories IDXX, based on the recent SEC filing. What Happened: Szostak's recent mo ...

Strong earnings, a $1.5B buyback, and game-changing diagnostics send Idexx stock soaring--investors take notice.

Presentation Operator Good morning, and welcome to the IDEX Laboratories 4th-Quarter 2024 Earnings Conference Call ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments. Idexx Laboratories offers a variety of products and diagnostic services ...

IDEXX Laboratories, Inc. ( NASDAQ: IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ET Brian McKeon - Chief Financial Officer Andrew Emerson - Senior Vice President, Corporate & ...

Idexx Laboratories primarily develops ... Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology ...